Characterization of long-term outcomes for pediatric patients with epithelioid hemangioma

AUTHORS

Liu KX , Duggan EM , Al-Ibraheemi A , Shaikh R , Adams DM , . Pediatric blood & cancer. 2018 9 11; 66(1). e27451

PMID: 30207085 [PubMed].

ABSTRACT

Epithelioid hemangioma (EH) is a rare benign vascular tumor that occurs in soft tissues and bone and presents between the third and sixth decades of life. Little is known about the clinical course and outcomes of pediatric EH. We report 11 patients diagnosed with EH at a median age of 14.4 years. One patient treated with interferon and one with sirolimus exhibited partial response for >2 years. Although a benign neoplasm, EH is difficult to manage without standard protocols and portends considerable morbidity. Our findings suggest medical management, particularly sirolimus, may benefit these patients; however, long-term follow-up is needed.

Tags: Alumni Publications 2018